Abstract Long COVID is an often debilitating illness that occurs in at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. More than 200 symptoms have been identifed with impacts on multiple organ systems. At least 65 million individuals worldwide are estimated to have long COVID, with cases increasing daily. Biomedical research has made substantial progress in identifying various pathophysiological changes and risk factors and in characterizing the illness; further, similarities with other viral-onset illnesses such as myalgic encephalomyelitis/chronic fatigue syndrome and postural orthostatic tachycardia syndrome have laid the groundwork for research in the feld. In this Review, we explore the current literature and highlight key fndings, the overlap with other conditions, the variable onset of symptoms, long COVID in children and the impact of vaccinations. Although these key fndings are critical to understanding long COVID, current diagnostic and treatment options are insufcient, and clinical trials must be prioritized that address leading hypotheses. Additionally, to strengthen long COVID research, future studies must account for biases and SARS-CoV-2 testing issues, build on viral-onset research, be inclusive of marginalized populations and meaningfully engage patients throughout the research process.
COVID-19 Vaccine Injury, Syndrome Not a Disease: FLCCC Conference Shares How to Treat It
The complex myriad of symptoms in people suspecting of COVID-19 vaccine injury has been given a new name and an extensive treatment protocol:
“Post-COVID-19 vaccines syndrome,” said Dr. Paul Marik, co-founder and Chief Science Officer of the Frontline COVID-19 Critical Care Alliance (FLCCC), on Oct. 15 at a conference in Orlando, Florida, aimed at education and sharing information on treating spike protein-induced health issues.
The Photoanalysis Remote Rife Clinic is specifically designed to help people with the multiple syndromes associated with COVID-19 and long COVID aftereffects. We were recently asked to work with an 86 year old women who went to emergency care and was told she could not come into the building and needed to wait outside on a park bench in sub-freezing weather. After an extended period of waiting with no-one showing up to help her she left. It is not a good idea to depend on a system that is crumbling and failing to help patients.
Follow the Science – COVID-19 Vaccine Mandates and the U.S. Military
The Pfizer-BioNTech COVID-19 mRNA preparation BNT162b2, now branded as Comirnaty™, is being mandated for U.S. military forces. It is virtually identical to the original and still highly controversial Pfizer-BioNTech BNT162b2 mRNA preparation. On Aug 24, 2021, after consultation with medical experts and military leaders and with the support of the White House, Secretary of Defense Lloyd J. Austin III stated that mandatory COVID-19 vaccinations for service members are necessary to protect the health and readiness of the force. This policy demonstrates a profound misunderstanding of the SARS-CoV-2 virus, the mRNA vaccines, and the current COVID-19 pandemic. The vaccination mandate will not reliably protect the health of our U.S. Special Operations air and ground forces and the intelligence agencies that support them. Instead, this mandate has the potential to generate both short and long-term incapacitating side effects within the age group that typifies Special Operations soldiers and contractors. Alternatively, it may increase the severity of COVID-19 in some fully vaccinated personnel who are later infected with one of the continuously evolving SARS-CoV-2 viral clades.
Frequency research has shown all those vaccinated may have compromised immune systems. Return to normal function can be achieved by running vaccine contaminant frequencies. All clients are tested for these frequencies and they have been released under the Creative Commons Share and Share Alike License so anyone can benefit. Click here for free access.
Real Science: DNA Analysis of COVID Strain Evolution in a Single Body
Last summer, at a hospital in England, a man in his 70s being treated for complications with cancer tested positive for covid-19. He had lymphoma, and the disease plus his drugs weakened his immune system, making him particularly susceptible to the virus. He wasn’t too bad off, considering, and was sent home. That was Day 1. This is the story of what the doctors witnessed, over the course of his illness: the evolution of covid-19 inside his body. Before their eyes, they get a hint of what might be to come in the pandemic. This episode was reported by Molly Webster. Special thanks to Ravindra Gupta, Jonathan Li. Support Radiolab by becoming a member today at Radiolab.org/donate. Want to learn more about some of the covid case studies? Here are a couple papers to get you started:The “U.K. Paper”, co-authored by Ravi Gupta, one of our sources for the episode: https://www.nature.com/articles/s41586-021-03291-y A case study out of Boston, co-authored by Dr. Jonathan Li, one of our sources for the episode: https://www.nejm.org/doi/full/10.1056/NEJMc2031364 For more on immune suppression and covid-19, check out this amazing Scientific American article: https://www.scientificamerican.com/article/covid-variants-may-arise-in-people-with-compromised-immune-systems/
Frequency implications are that infection with COVID-19 causes multiple different mutated strain COVID infections creating symptoms in many different organ systems over time. Ongoing frequencies targeted at specific strains emerging are needed. Also in the case discussed, the patient ultimately died of pneumonia so coinfections must be eliminated simultaneuosly.
The “vaccine” which is an experimental genetic modification treatment not covered under the U.S. Vaccine act will likely suppress symptoms but not the ongoing evolution of COVID strains discussed in this episode.
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.